Zobrazeno 1 - 10
of 1 363
pro vyhledávání: '"VAN VOLLENHOVEN, P."'
Autor:
Ronald van Vollenhoven, Vibeke Strand, Tsutomu Takeuchi, Nilmo Chávez, Pablo Mannucci Walter, Atul Singhal, Jerzy Swierkot, Nasser Khan, Xianwei Bu, Yihan Li, Sara K. Penn, Heidi S. Camp, Jacob Aelion
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-15 (2024)
Abstract Background To evaluate the efficacy and safety of upadacitinib monotherapy versus methotrexate (MTX) monotherapy over 5 years among MTX-naïve patients with moderately to severely active rheumatoid arthritis (RA) in the long-term extension (
Externí odkaz:
https://doaj.org/article/d96238b03a104e99a640cf8bd22d5e92
Autor:
Ronald F van Vollenhoven, Danielle M Gerlag, Karen I Maijer, Sander W Tas, Niek de Vries, Paul P Tak, Robert B M Landewé, Lisa G M van Baarsen, Giulia Frazzei, Sophie H M Cramer
Publikováno v:
RMD Open, Vol 10, Iss 4 (2024)
Objectives Early treatment of individuals at risk of developing rheumatoid arthritis (RA-risk) in the preclinical phase has the potential to positively impact both patients and society by preventing disease onset and improving patients’ quality of
Externí odkaz:
https://doaj.org/article/1523f082a9b24d84afb908de20f35ef4
Autor:
Agner R. Parra Sánchez, Ronald F. van Vollenhoven, Eric F. Morand, Ian N. Bruce, Rangi Kandane-Rathnayake, Gudrun Weiss, Raj Tummala, Hussein Al-Mossawi, Alessandro Sorrentino
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 4, Pp 1059-1061 (2024)
Externí odkaz:
https://doaj.org/article/808b953d2a8f4ae5a7971d120b868f7e
Autor:
Jianyang Liu, Helena Idborg, Marina Korotkova, Kristina Lend, Ronald van Vollenhoven, Jon Lampa, Anna Rudin, Dan Nordström, Bjorn Gudbjornsson, Gerdur Gröndal, Till Uhlig, Kim Hørslev-Petersen, Merete Lund Hetland, Mikkel Østergaard, Michael Nurmohamed, Per-Johan Jakobsson
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-9 (2024)
Abstract Background Disease-modifying antirheumatic drugs (DMARDs) are widely used for treating rheumatoid arthritis (RA). However, there are no established biomarkers to predict a patient’s response to these therapies. Prostanoids, encompassing pr
Externí odkaz:
https://doaj.org/article/2260d524aa2942c78c1315d2c24d7266
Autor:
Ronald F van Vollenhoven, Roy Fleischmann, Stephen Hall, Yanna Song, Sebastian Meerwein, Alvin F Wells, Oishi Tanjinatus
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Objective To evaluate the long-term sustainability of response to the Janus kinase inhibitor upadacitinib among patients with rheumatoid arthritis and an inadequate response or intolerance to biological disease-modifying antirheumatic drugs (bDMARD-I
Externí odkaz:
https://doaj.org/article/586ca3e848a64b7e8e3e8f420081088c
Autor:
Munther Khamashta, Richard A Furie, Ian N Bruce, Ronald van Vollenhoven, Murray B Urowitz, Andreas Schwarting, Ming-hui Zhao, Anca D Askanase, Mark Daniels, Andrew S Bomback, Angela Carroll, Bernie Rubin, Roger Abramino Levy
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 1 (2024)
Our 2022 published working definition of disease modification in systemic lupus erythematosus (SLE) was ‘minimising disease activity with the fewest treatment-associated toxicities and slowing or preventing organ damage progression’. The objectiv
Externí odkaz:
https://doaj.org/article/3978731451ab4b52af1def567e5d6564
Autor:
Richard A Furie, Eric F Morand, Sule Yavuz, Kenneth C Kalunian, Gabriel Abreu, Ronald van Vollenhoven, Catharina Lindholm, Hussein Al-Mossawi
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 2 (2024)
Externí odkaz:
https://doaj.org/article/208c126998ad4903b38cb363180c8520
Autor:
Joan T Merrill, Ronald F van Vollenhoven, Daniel J Wallace, Susan Manzi, Cynthia Aranow, Anca Askenase, Michelle A Petri, Jill Buyon, Rosalind Ramsey-Goldman, Ian N Bruce, Guillermo Ruiz-Irastorza, Ellen M Ginzler, Graciela S Alarcón, John G Hanly, Murray B Urowitz, Juanita Romero-Diaz, Caroline Gordon, Sang-Cheol Bae, Anisur Rahman, Mary Anne Dooley, Paul R Fortin, Meggan Mackay, Andreas Jönsen, Sam Lim, Murat Inanc, Diane L Kamen, Christine A Peschken, Søren Jacobsen, Jorge Sanchez-Guerrero, David Isenberg, Marvin J Fritzler, Ann E Clarke, Sasha Bernatsky, Kenneth C Kalunian, Eugene Krustev, May Y Choi, Katherine A Buhler, Ricky Chin
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 1 (2024)
Background Cranial neuropathies (CN) are a rare neuropsychiatric SLE (NPSLE) manifestation. Previous studies reported that antibodies to the kinesin family member 20B (KIF20B) (anti-KIF20B) protein were associated with idiopathic ataxia and CN. We as
Externí odkaz:
https://doaj.org/article/9208cd215f174ca8b2697b5bb89d40f3
Autor:
Ronald F van Vollenhoven, Merete Lund Hetland, Till Uhlig, Espen A Haavardsholm, Dan Nordström, Mikkel Østergaard, Michael T Nurmohamed, Sizheng Steven Zhao, Alf Kastbom, Bjorn Gudbjornsson, Meliha Crnkic Kapetanovic, Gerður Gröndal, Yuan Zhang, Kim Hørslev-Petersen, Anna Rudin, Jon Lampa, Kristina Lend, Tuulikki Sokka-Isler, Annika Söderbergh, Milad Rizk, Cristina Maglio, Marte Schrumpf Heiberg, Violetta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective This report from the NORD-STAR (Nordic Rheumatic Diseases Strategy Trials and Registries) trial aimed to determine if obesity is associated with response to conventional and biological antirheumatic treatment in early rheumatoid arthritis (
Externí odkaz:
https://doaj.org/article/6b01938d1e354a908fc7fc126fb8f00b
Autor:
Agner R. Parra Sánchez, Ronald F. van Vollenhoven, Eric F. Morand, Ian N. Bruce, Rangi Kandane-Rathnayake, Gudrun Weiss, Raj Tummala, Hussein Al-Mossawi, Alessandro Sorrentino
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1459-1477 (2023)
Abstract Remission is the established therapeutic goal for patients with systemic lupus erythematosus (SLE) and is currently defined by the widely adopted Definition Of Remission In SLE (DORIS) criteria. Attainment of remission is rare in the clinica
Externí odkaz:
https://doaj.org/article/e1fcf1e203f84ba88cc0a6c10e3a1017